Results presented at the 2019 NCPA Annual Convention
Governor Pritzker pushing for lighter pharmacy workloads.
Common collaborations include allergy, antibiotic, and opiate consultations.
Commercial launch suspended due to manufacturer liquidity.
What execs and experts think of the future of drug costs.
Fifth company warned about unsubstantiated claims this year.
Approved in May 2019, granted to FoldRx, a subsidiary of Pfizer.
Previously approved for IV infusion.
Fourth indication expansion for the 2009 drug.
What to expect for these high-dollar drugs.